Zydus Lifesciences pulled up by FDA over quality-control issues

The US health regulator, in a letter to the pharma company, accuses it of violating good manufacturing practices at its Vadodara plant.

September 15, 20242 min
0
Zydus Lifesciences pulled up by FDA over quality-control issues

You may also like

Business
Story image

Dr. Reddy’s wants to be India’s fifth largest drugmaker. What will it take?

The stock market has taken note of the company’s ambitious plans in the domestic market. But the path ahead is far from easy.

Internet
Story image

Why quick delivery of medicines will be difficult to scale

Quick-commerce apps are likely to run into regulations and poor order volumes as they try to grow this business.

Health
Story image

Indian pharma exporters protesting against new regulations is not a good look

The rules require exporters of certain drugs to get an NOC from importing countries—a small but much-needed step to restoring India’s credibility in the global pharma market.